Oral Health Screenings for Preventative Health in a Free Clinic Population

Autor: Geisler, Reed, Yanamadala, Vivek, Mannix, Nick, Kumar, Nicolas, Vardanyan, Jon, Georgy, Mark, Ilesh Patel, Konstan, Robert, Patel, Prit, Rotenberg, Shaun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::540a8e7dda92982569f3914f6ef2ba06

Metformin Affects the Proliferation Cell Nuclear Antigen (PCNA) and p21 Protein Interaction Resulting in Direct Anti-Tumor Activity and Enhances the Cytotoxic/Biological Effects of Chemotherapy Agents or Rituximab in Lymphoma in Vitro and in Vivo Pre-Clinical Models

Autor: Gu, Juan J ^*, Yanamadala, Vivek ^*, Singh, Anil ^*, Mavis, Cory ^*, Czuczman, Myron S., Hernandez, Francisco

Publikováno v: In Blood 6 December 2014 124(21):1781-1781

Altered Glucose Metabolism In Rituximab-Chemotherapy Resistant Cells Is a Potential Target For Future Therapeutic Development

Autor: Gu, Juan, Yanamadala, Vivek, Mavis, Cory, Hernandez, Francisco, Czuczman, Myron S.

Publikováno v: In Blood 15 November 2013 122(21):4413-4413

Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development.

Autor: Gu JJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Singh A; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Xue K; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Mavis C; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Barth M; Department of Pediatric Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Yanamadala V; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA., Lenz P; Department of Physics, Philipps-University, Marburg, Germany., Grau M; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Lenz G; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Czuczman MS; Celgene, Summit, New Jersey, USA., Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA.; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.

Publikováno v: Oncotarget [Oncotarget] 2017 Dec 19; Vol. 9 (3), pp. 4020-4033. Date of Electronic Publication: 2017 Dec 19 (Print Publication: 2018).